Skip to content
Governance Register

Company · Cambridge

F-Star Therapeutics Limited

Research and experimental development on biotechnology

Official record Companies House · updated 27th September 2026 · Sources

Network

The large node is F-Star Therapeutics Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.

Who leads it

Previous officers 15

  1. Ryan William Fiehler 2025-2025 Director View profile
  2. John Paul Fitzpatrick 2020-2021 Director View profile
  3. Geoffrey Robin Race 2019-2020 Director View profile
  4. Edward John Benz Jr 2019-2020 Director View profile
  5. Dr Jean-Francois Formela 2019-2020 Director View profile
  6. Dr Deborah Harland 2019-2020 Director View profile
  7. Nessan Anthony Bermingham 2019-2020 Director View profile
  8. Patrick Johan Hendrik Krol 2019-2020 Director View profile
  9. Dr Florian Ruker 2019-2019 Director View profile
  10. John Blodgett Edwards 2019-2019 Director View profile
  11. Eliot Richard Forster 2019-2023 Director View profile
  12. Helmut Schuehsler 2019-2020 Director View profile
  13. Tolga Hassan 2018-2019 Director View profile
  14. John Paul Fitzpatrick 2020-2021 Secretary View profile
  15. Tolga Hassan 2019-2020 Secretary View profile

Directors and secretaries as filed at Companies House.

Do you help lead this organisation? Set up its network · How it works

About

What it does
Research and experimental development on biotechnology
Incorporated
22/08/2018
Registered office
Cambridge

Ownership

Owned by (3) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.

  • John Edward Lash
    75-100% shares, 75-100% voting, appoints directors · notified 2025-04-02
  • Tolga Hassan ceased 2019-05-07
    75-100% shares, 75-100% voting, appoints directors · notified 2018-08-22 - confirmed: also a director of this company
  • Invox Pharma Limited ceased 2025-04-02
    75-100% shares, 75-100% voting · notified 2023-03-08

Group

  1. F-Star Therapeutics Limited is controlled by John Edward Lash
    Evidence
    active 75-100% shares, 75-100% voting, appoints directors · notified 2025-04-02 · source: Companies House PSC register

Ultimately controlled by John Edward Lash.

4 other companies in this group

Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.

Grants received

2 grants · £381,748 total

360Giving data, published by funders. Coverage only includes funders who publish their grants to 360Giving, so these figures are a floor, not a complete picture.

Top funders

  • Department for Business, Energy and Industrial Strategy · £381,748 (2 grants)

Most recent

  • Department for Business, Energy and Industrial Strategy £56,9192020-06-01
  • Department for Business, Energy and Industrial Strategy £324,8292020-04-01
Board analysis

Board DNA

How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.

2 directors on the board

2.3y median 2.3y
average tenure
3.4y
longest tenure
0
directors past 6 years

First-time vs portfolio directors

First-time (1)

Portfolio (1)

0
also govern a charity

Left in the last 12 months

Sources

Official record from Companies House. Governance Register calculates the connections.

Record details
Company number
11532458
Status
Active
Type
Private Limited Company
Accounts next due
30/09/2027
Edition
Register edition compiled 27th September 2026
Labels
Official record from Companies House · Calculated derived by Governance Register.

Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data